Drug Information

General Information
Drug ID
DR00213
Drug Name
Sincalide
Synonyms
CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated)
Drug Type
Small molecular drug
Indication Discovery agent [ICD11: N.A.] preclinical [1]
Structure
3D MOL 2D MOL
Formula
C49H62N10O16S3
Canonical SMILES
CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N
InChI
InChI=1S/C49H62N10O16S3/c1-76-18-16-34(55-47(69)37(58-44(66)32(50)23-41(61)62)21-28-12-14-30(15-13-28)75-78(72,73)74)45(67)53-26-40(60)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(70)56-35(17-19-77-2)46(68)59-39(24-42(63)64)49(71)57-36(43(51)65)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52H,16-24,26,50H2,1-2H3,(H2,51,65)(H,53,67)(H,54,60)(H,55,69)(H,56,70)(H,57,71)(H,58,66)(H,59,68)(H,61,62)(H,63,64)(H,72,73,74)/t32-,34-,35-,36-,37-,38-,39-/m0/s1
InChIKey
IZTQOLKUZKXIRV-YRVFCXMDSA-N
CAS Number
CAS 25126-32-3
Pharmaceutical Properties Molecular Weight 1143.3 Topological Polar Surface Area 486
Heavy Atom Count 78 Rotatable Bond Count 33
Hydrogen Bond Donor Count 13 Hydrogen Bond Acceptor Count 19
XLogP
-2.6
PubChem CID
9833444
PubChem SID
103316441 , 123121353 , 131307304 , 134346207 , 134997521 , 135651651 , 137240153 , 144206508 , 144207030 , 14792525 , 162182548 , 164814310 , 187072152 , 218903095 , 226493679 , 241182191 , 24133261 , 252359174 , 44931550 , 47207506 , 49689220 , 49689221 , 50112569 , 53789477 , 57373462 , 77763993
ChEBI ID
CHEBI:135946
TTD Drug ID
D0I8AF
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [3]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [4]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OATP1B3 Transporter Info Km = 11.1 microM Oocytes-OATP1B3 [5]
References
1 ClinicalTrials.gov (NCT00706381) Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
2 Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells. Mol Pharmacol. 2005 Oct;68(4):1031-8.
3 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.
4 Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J Med Chem. 2012 May 24;55(10):4740-63.
5 Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology. 2001 Nov;121(5):1185-90.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.